Article
Oncology
Duanyang Zhai, Tianfu Li, Runyi Ye, Jiong Bi, Xiaying Kuang, Yawei Shi, Nan Shao, Ying Lin
Summary: This study identified that the lncRNA LGALS8-AS1 is highly expressed in breast cancer and promotes the metastasis of breast cancer cells. LGALS8-AS1 upregulates SOX12 by sponging miR-125b-5p, thus activating the PI3K/AKT signaling pathway to facilitate breast cancer metastasis. The reciprocal regulatory loop of LGALS8-AS1/miR-125b-5p/SOX12 may serve as a potential therapeutic target for breast cancer treatment.
FRONTIERS IN ONCOLOGY
(2021)
Article
Reproductive Biology
Yang Shen, Mengmeng Lv, Yichen Fang, Jin Lu, Yuzhong Wu
Summary: In this study, it was found that MNX1-AS1 promotes ovarian cancer (OC) development through the miR-744-5p/SOX12 axis. MNX1-AS1 was upregulated in OC tumor tissues and cells, competitively binding with miR-744-5p and affecting cell proliferation, migration, invasion, and apoptosis. This novel mechanism of MNX1-AS1 in OC may provide a new treatment target for this malignancy.
JOURNAL OF OVARIAN RESEARCH
(2021)
Article
Gastroenterology & Hepatology
Tao Wan, Jun Zheng, Rucheng Yao, Shuang Yang, Weihong Zheng, Pei Zhou
Summary: In this study, it was found that DDX11-AS1 is upregulated in HCC, and its silencing can inhibit HCC cell proliferation, migration, invasion, and glucose metabolism while promoting apoptosis. Additionally, DDX11-AS1 interacts with miR-195-5p and MACC1, suggesting it may serve as a potential therapeutic target for HCC.
ANNALS OF HEPATOLOGY
(2021)
Article
Biochemistry & Molecular Biology
Wen-guang Ma, Si-mao Shi, Lu Chen, Ge Lou, Xiao-ling Feng
Summary: FOXD3-AS1 is overexpressed in cervical cancer and associated with disease progression, possibly through modulation of miR-296-5p and high mobility group A-mediated tumor promotion.
JOURNAL OF CELLULAR BIOCHEMISTRY
(2021)
Article
Cell Biology
Zhifu Gui, Zhenguo Zhao, Qi Sun, Guoyi Shao, Jianming Huang, Wei Zhao, Yuting Kuang
Summary: Long non-coding RNA FEZF1-AS1 is upregulated in gastric cancer tissues and cell lines, and is associated with chemoresistance. High expression of FEZF1-AS1 is an independent predictor for poor overall survival in gastric cancer patients, potentially regulating multi-drug resistance through modulating autophagy in gastric cancer cells.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
(2021)
Article
Cell Biology
Renbo Guo, Benkui Zou, Yiran Liang, Jiasheng Bian, Jian Xu, Qian Zhou, Chao Zhang, Tao Chen, Mingshan Yang, Huansheng Wang, Fajun Pei, Zhonghua Xu
Summary: This study identified an uncharacterized and upregulated lncRNA RCAT1 in renal cell carcinoma, which played a key role in cell proliferation and metastasis by modulating the miR-214-5p/E2F2 axis, suggesting that lncRNA RCAT1 might be a new prognostic biomarker and potential therapeutic target for renal cell carcinoma.
CELL DEATH & DISEASE
(2021)
Article
Oncology
Yun Wang, Kai Tan, Wen Hu, Yan Hou, Guang Yang
Summary: This study identifies a novel long non-coding RNA (lncRNA), AC026401.3, that promotes sorafenib and lenvatinib resistance in HCC cells. The findings suggest that targeting the AC026401.3-OCT1-E2F2 signaling axis could be a promising strategy for HCC therapeutics.
EXPERIMENTAL CELL RESEARCH
(2022)
Article
Cell Biology
Jianguo Yao, Xiaojian Liu
Summary: Hepatocellular carcinoma (HCC) is a highly prevalent and deadly malignancy due to the lack of effective biomarkers and treatments. This study identified LncRNA PITPNA antisense RNA 1 (PITPNA-AS1) as an oncogenic factor in HCC. It was found that PITPNA-AS1 expression was significantly increased in HCC and correlated with poor prognosis. In vitro experiments demonstrated that downregulation of PITPNA-AS1 inhibited malignant activities of HCC cells. Additionally, PITPNA-AS1 was found to act as a competing endogenous RNA (ceRNA) that regulates the expression of platelet-derived growth factor-D (PDGFD) by sponging miR-363-5p. These findings highlight the involvement of the PITPNA-AS1/miR-363-5p/PDGFD regulatory axis in HCC progression.
Article
Medicine, Research & Experimental
Yuqin Ding, Yuting Huang, Fanrong Zhang, Lijie Gong, Chenlu Liang, Kaijing Ding, Xiangming He, Xiaowen Ding, Yiding Chen
Summary: Our study investigated the role of lncRNA TDRKH-AS1 in breast cancer (BC). We found that TDRKH-AS1 was upregulated in BC tissues and cell lines, and its high expression was associated with advanced stages and poor outcomes in BC patients. Knockdown of TDRKH-AS1 inhibited BC cell proliferation and invasion. Mechanistically, TDRKH-AS1 acted as a sponge for miR-134-5p, thereby promoting the expression of cAMP response element-binding protein 1 (CREB1), a downstream target of miR-134-5p. In vivo experiments confirmed the tumor-promoting role of TDRKH-AS1 in BC.
JOURNAL OF TRANSLATIONAL MEDICINE
(2023)
Article
Pharmacology & Pharmacy
Haiyun Zhang, Ruijuan Guan, Zili Zhang, Defu Li, Jingyi Xu, Yuxin Gong, Xin Chen, Wenju Lu
Summary: The study identified that Nqo1-AS1 attenuates cigarette smoke-induced oxidative stress by regulating Nqo1 gene expression, suggesting it as a potential novel approach for the treatment of chronic obstructive pulmonary disease (COPD).
FRONTIERS IN PHARMACOLOGY
(2021)
Article
Cell Biology
Kun Yan, Chunyan Hu, Chen Liu, Guanghua Chu, Xinru Wang, Shuyun Ma, Long Li
Summary: CERS6-AS1 is upregulated in cervical cancer tissues and cells, promoting proliferation and invasion while inhibiting apoptosis. It functions as a sponge for miR-6838-5p, leading to upregulation of FOXP2 expression and further enhancing cell proliferation and invasion. Therefore, CERS6-AS1 may be a potential therapeutic target for cervical cancer.
HISTOLOGY AND HISTOPATHOLOGY
(2023)
Article
Cell & Tissue Engineering
Z. Li
Summary: The study aims to explore the role of lncRNA PCBP1-AS1 in the pathogenesis of osteoporosis. The results suggest that PCBP1-AS1 regulates the proliferation and osteogenic differentiation capacity of human bone marrow-derived mesenchymal stem cells and promotes the expression of PAK2 through competitive binding with miR-126-5p, thereby promoting the progression of osteoporosis.
BONE & JOINT RESEARCH
(2023)
Article
Biotechnology & Applied Microbiology
Yang Bai, Chenchen Ren, Baojin Wang, Jingge Xue, Feiyan Li, Jiaxi Liu, Li Yang
Summary: Recent studies have shown that MAFG-AS1 stimulates the malignant progression of OC by upregulating NFKB1-mediated IGF1 via miR-339-5p, highlighting a potential novel therapeutic target against OC.
CANCER GENE THERAPY
(2022)
Article
Cell Biology
Jian Cao, Huan Wang, Guangquan Liu, Ranran Tang, Ye Ding, Pengfei Xu, Huayu Wang, Juan Miao, Xiaoyan Gu, Suping Han
Summary: LBX2-AS1 is a novel cancer-promoting long non-coding RNA in ovarian cancer, which enhances the growth, invasion, migration, and tumour formation capabilities of ovarian cancer cells by inhibiting miR-455-5p and miR-491-5p, thus liberating the expression of the E2F2 cancer-promoting gene.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
(2021)
Article
Dentistry, Oral Surgery & Medicine
Yuchao Zhang, Feng Wang, Yang Yu
Summary: In this study, the expression, biological roles, and potential mechanisms of lncRNA HOXD cluster antisense RNA 1 (HOXD-AS1) in oral squamous cell carcinoma (OSCC) were investigated. It was found that HOXD-AS1 may upregulate Annexin A4 by sponging miR-203a-5p in OSCC, promoting cancer cell invasion and migration.